By rray, 9 February, 2023 Consider early combo tx at tx initiation to shorten time to attainment of individualized tx goals A
By rray, 9 February, 2023 Re evaluate medication plan and medication taking behavior at regular intervals e g q3 6mo and adjust as needed to incorporate specific factors that impact choice of tx E
By rray, 9 February, 2023 Don t delay tx modification intensification or deintensification for adults not meeting individualized tx goals A
By rray, 9 February, 2023 Use pharmacological strategies that provide sufficient effectiveness to achieve and maintain intended tx goals A
By rray, 9 February, 2023 Glucose lowering tx plan should consider approaches that support wt mgmt goals A
By rray, 9 February, 2023 Use a person centered shared decision making approach to guide choice of pharmacologic agents Consider effects on CV and renal comorbidities effectiveness hypoglycemia risk impact on wt cost and access risk for adverse reactions and tolerability and indiv
By rray, 9 February, 2023 Consider healthy lifestyle behaviors DM self mgmt education and support DSMES avoidance of therapeutic inertia and social determinants of health SDOH when choosing glucose lowering tx A
By rray, 9 February, 2023 No clear evidence that dietary supplements e g herbs and botanicals high dose vitamins and minerals amino acids enzymes antioxidants etc are effective for obesity mgmt wt loss 6 Supplementation of certain vitamins and minerals e g iron vit B12 vit D may b